Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material.
about
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodiesThe clinical application of monoclonal antibodies in chronic lymphocytic leukemia.Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis.Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.Stem cell transplantation for multiple myeloma.The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation.A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface.Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDCMonoclonal antibodies in treatment of multiple sclerosis.Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.Metabolic and safety issues for multiple sclerosis pharmacotherapy--opportunities for personalised medicine.Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models.Cancer Immunotherapies: Are They as Effective in the Elderly?Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells.Immunosuppressive toxicity of CAMPATH1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma.Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells.A functional fibroblast growth factor-1 immunoglobulin fusion protein.Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis
P2860
Q21131216-49ABC56F-356C-485B-BB02-FD3705A02A71Q34310845-3DB87D02-9335-42CD-B42F-B1703973165EQ34326110-ABA9680A-5FF8-48BB-8892-96598D98DE09Q34409273-92E3C875-28E8-48EE-80BE-B69C96BA8067Q35692626-C0903282-2B4E-4E0C-A62A-3928AEC95C3BQ35866482-18DFA77B-D735-4A15-B315-23B387BCDD32Q35886917-8D1EE9D0-087C-4670-AE79-30E6D8E82FD2Q36363690-7AE9F831-3108-450F-B82D-C39B384A27CAQ37403194-B63C9AE0-63E9-4F96-B442-5BA77B4B2555Q38133865-A26DC60F-1D49-4D91-A3BF-E3AC6CA2451FQ38150405-CEDE614D-DCFA-483E-BF79-44DE18FDFDB2Q38173374-0029F3C1-9208-4A7B-B8F4-1D959F0381EDQ38218692-FBAFD181-FE78-4A79-AA20-478236C7E784Q38256670-64C04806-500D-4E31-B0AC-CB30B08D8841Q38679662-6B89DE61-F998-48C1-8BA7-C3F7D3DDFF63Q39422339-0076B6A3-5641-433D-8246-4387A71D6FF6Q40660292-146243E3-A9CB-4A5A-9289-B6B908EF61D5Q40993369-36EC3699-3F50-407E-A32B-6E4B63E2CD75Q42829017-1BAFA905-9192-4BD5-A9EA-C1247FE34BFDQ59129976-6688968C-DDFE-4379-B7C8-18F9BC780586
P2860
Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Humanized monoclonal antibody ...... r ovary cell-derived material.
@en
type
label
Humanized monoclonal antibody ...... r ovary cell-derived material.
@en
prefLabel
Humanized monoclonal antibody ...... r ovary cell-derived material.
@en
P2093
P2860
P1476
Humanized monoclonal antibody ...... r ovary cell-derived material.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2249.1992.TB06421.X
P577
1992-01-01T00:00:00Z